UK Health Protection Agency (HPA) recommends universal HIV testing in the high incidence regions of the UK
1 December 2011. Related: HIV prevention and transmission.
HIV prevention and transmission
Orange Farm circumcision results dispel concerns about risk compensation
1 October 2011. Related: Conference reports, HIV prevention and transmission.
DSMB stops oral tenofovir monotherapy arm of VOICE PrEP study due to lack of difference compared to placebo
1 October 2011. Related: HIV prevention and transmission.
Treatment is prevention: ARV treatment in HPTN-052 reduces transmission by at least 96%: single transmission in treatment arm occurred before viral suppression
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Daily oral tenofovir/FTC PrEP reduces heterosexual transmission by 63% in the TDF2 study
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Tenofovir/FTC vs tenofovir as daily oral PrEP: preliminary results from Partners PrEP
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
HPTN 052 study stopped early: significant reduction in HIV transmission from early use of HIV treatment in serodifferent partners
1 August 2011. Related: HIV prevention and transmission.
Preventive technologies, immune-based and gene therapies, and research towards a cure
14 July 2011. Related: HIV prevention and transmission, Basic science and immunology, Vaccines and microbicides.
FEM-PrEP prevention study using daily Truvada halted during enrolment: interim analysis shows similar infection rates in active and placebo arms
1 May 2011. Related: HIV prevention and transmission.
US CDC issue preliminary guidance for use of PrEP
1 February 2011. Related: HIV prevention and transmission.
Pre-exposure prophylaxis (PrEP) with tenofovir/FTC reduces sexual transmission of HIV between men at high risk: results from the iPrEx study
1 December 2010. Related: HIV prevention and transmission.
Male circumcision retains effectiveness at reducing risk of HIV infection: 54 month results
1 October 2010. Related: Conference reports, HIV prevention and transmission.
Results from the Caprisa 004 tenofovir microbicide trial
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Quadrivalent HPV vaccine reduces genital lesions and HPV acquisition in men
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Lime juice is not a microbicide: do not try at home
26 August 2010. Related: Conference reports, Women's health, HIV prevention and transmission.
Immune-based therapies and preventive technologies pipeline
1 July 2010. Related: Pipeline report, HIV prevention and transmission, Basic science and immunology, Vaccines and microbicides.
Summaries of other studies
1 June 2010. Related: Conference reports, HIV prevention and transmission.
HIV reinfection cases reported at CROI
1 June 2010. Related: Conference reports, HIV prevention and transmission, Virology.
Treatment reduces infections by over 90%: a theme that is here to stay
2 April 2010. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Male circumcision: new data supporting protective mechanism
4 February 2010. Related: HIV prevention and transmission.
A caution for male circumcision programmes: high complication rates highlighted outside a trial setting
4 February 2010. Related: HIV prevention and transmission.
HIV reinfection reported in 10% of couples in Zambian study
26 December 2008. Related: Conference reports, HIV prevention and transmission.
Intermittent tenofovir/FTC PrEP offers monkeys some protection
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Tenofovir/FTC gel protects female monkeys from SHIV
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Recently infected HIV-positive Quebec residents cause more than half of new cases
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Common estimate of heterosexual HIV transmission risk sometimes far too low
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Implications of transmission with undetectable HIV viral load: lower limit for HIV transmission excluded from model
30 October 2008. Related: HIV prevention and transmission.
Case report of sexual transmission when viral load suppressed to <50 copies/mL
30 October 2008. Related: HIV prevention and transmission.
HIV RNA is detectable in semen in 5% patients with undetectable blood plasma viral attending fertility clinic
30 October 2008. Related: HIV prevention and transmission.
Tenofovir gel as a rectal microbicide: evidence for protection and priming of T-cell responses in the SIV challenge model
30 October 2008. Related: HIV prevention and transmission.
Genetic protection against malaria may increase susceptibility to HIV infection in people of African decent
30 October 2008. Related: HIV prevention and transmission.
US CDC issue reports of false-positive oral rapid tests in New York HIV testing programme
30 October 2008. Related: HIV prevention and transmission.
Epidemiological studies and transmission of resistance: evidence for optimism or issues with interpretation?
3 August 2006. Related: Conference reports, HIV prevention and transmission, Drug resistance.
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
12 May 2006. Related: Conference reports, HIV prevention and transmission.
K65R frequently emerges within 1-6 weeks of tenofovir monotherapy in macaques
12 May 2006. Related: Conference reports, HIV prevention and transmission.
A genome armed against HIV
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Circumcision: a surprising benefit from an unkind cut
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Topical microbicides: the real front line of HIV prevention
12 May 2006. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
HSV-2 suppression reduces HIV and HSV shedding
12 April 2006. Related: Conference reports, HIV prevention and transmission.
Adult male circumcision reduces transmission rates over 18 months comparable to a vaccine with 65% efficacy
14 September 2005. Related: Conference reports, HIV prevention and transmission.
Lack of keratin overlaying inner foreskin may explain lower HIV infection rates in circumcised men
6 September 2004. Related: Conference reports, HIV prevention and transmission.
Sexual transmission of HIV by acutely infected individuals has a disproportionate effect on the spread of HIV and may explain the current pandemic
29 July 2004. Related: HIV prevention and transmission.
Transmission of drug resistance – at 11% in Europe and 17% in the UK
1 September 2003. Related: Conference reports, HIV prevention and transmission, Drug resistance.
HIV coinfection, reinfection and superinfection
1 September 2003. Related: Conference reports, Hepatitis coinfection, HIV prevention and transmission, Drug resistance.
A case of intraclade HIV-1 superinfection by wild-type virus illustrates the potential to impact disease progression
1 June 2003. Related: HIV prevention and transmission.
Diagnosis of acute HIV infection: it’s time to get moving!
17 January 2001. Related: HIV prevention and transmission.